US Patent

US8618075 — Certain compounds, compositions and methods

Method of Use · Assigned to Eisai Inc · Expires 2028-10-16 · 2y remaining

Vulnerability score 75/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects certain tetrahydrouridine derivative compounds, compositions, and kits, and methods of making and using these compounds.

USPTO Abstract

The present invention provides certain tetrahydrouridine derivative compounds, pharmaceutical compositions and kits comprising such compounds, and methods of making and using such compounds.

Drugs covered by this patent

cedazuridine (CEDAZURIDINE)

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-2864`	—	cedazuridine

Patent Metadata

Patent number: US8618075
Jurisdiction: US
Classification: Method of Use
Expires: 2028-10-16
Drug substance claim: No
Drug product claim: No
Assignee: Eisai Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.